The World Development Indicators (WDI) is the primary World Bank collection of development indicators, compiled from officially recognized international sources. It presents the most current and accurate global development data available, and includes national, regional and global estimates. You can create your own queries; generate tables, charts, and maps; and easily save, embed, and share them. (From the World Bank DataBank website). It is one of the databases in the World Bank DataBank.
Due to constraints in vaccine supply, this agent-based model of COVID-19 transmission was developed to compare the impact of two vaccination strategies: 1) vaccinate more individuals with the first dose of available vaccines and delay the second dose or 2) to continue with the recommended 2-dose series as tested in clinical trials. Model population was stratified into 6 age groups of 0 to 4, 5 to 19, 20 to 49, 50 to 64, 65 to 79, and 80+ years based on United States census data.
To improve reporting transparency and research integrity, some journals have begun publishing study protocols and statistical analysis plans alongside trial publications. To determine the overall availability and characteristics of protocols and statistical analysis plans this study reviewed all randomized clinical trials (RCT) published in 2016 in the following 5 general medicine journals: Annals of Internal Medicine, BMJ, JAMA, Lancet, and NEJM. Characteristics of RCTs were extracted from the publication and clinical trial registry. A detailed assessment of protocols and statistical analysis plans was conducted in a 20% random sample of trials. Dataset contains extraction sheets (as SAS data files), code to calculate the values in the tables in the manuscript, and a supplemental file with additional notes on methods used in the study.
The Global Health Data Exchange (GHDx) is a catalog that provides relevant data on population health. The catalog contains surveys, censuses, vital statistics, and other health-related data. The GHDx was created by the Institute for Health Metrics and Evaluations (IHME), an independent global health research center at the University of Washington. The GHDx is a place where information about data is brought together, discussed, and featured in the context of health and demographic research. The GHDx raises awareness about different groups collecting data worldwide and provides standardized citations to encourage appropriate acknowledgment of data owners’ contributions.
This study investigated demographic trends over time in the use of prescription opioids versus heroin among addicted individuals. ICD9 codes associated with hospitalizations for overdoses from either prescription opioids (POD) or heroin (HOD) were harvested from the Nationwide Inpatient Sample (NIS) for the years 1993 through 2009, inclusive. Population data were taken from U.S. Census statistics. Demographic specific rates of POD and HOD hospital admissions were analyzed to determine if fluctuations in the dynamics of one form of opiate, such as supply-based reduction, are correlated with changes in the rates of overdoses of the other. Dataset includes statistical and demographic data.
Dataset is comprised of heroin overdose-related and prescription opioid overdose-related hospitalization rates for the years 2000 through 2014. Data is derived from the Healthcare Cost and Utilization Project (HCUP) Nationwide Inpatient Sample (NIS). Included are rates by census region and division with separate rates for age and race.
Dataset comprises hospitalization rates for opioid injection-related skin and soft-tissue infections (O-SSTI) correlated with changes in the price and purity of heroin for the years 1993 through 2010, inclusive. Data is derived from the Healthcare Cost and Utilization Project (HCUP) Nationwide Inpatient Sample (NIS) and the Drug Enforcement Administration (DEA) System to Retrieve Information from Drug Evidence (STRIDE) databases for 27 Metropolitan Statistical Areas (MSAs).